Clinical Trial Update: Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interleukin-11 to address thrombocytopenia in chronic myeloid leukemia patients treated with imatinib. The study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Oprelvekin (oprelvekin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-05-04